C. Jason Mallo, DO. Division Medical Director, MMC Department of Psychiatry, Adult Outpatient Psychiatry; Assistant Clinical Professor, Tufts University School of Medicine.
Dr. Mallo has no financial relationships with companies related to this material.
Sarah Azarchi, MD. Dr. Azarchi has no financial relationships with companies related to this material.
Alex Evans, PharmD, MBA. Dr. Evans has no financial relationships with companies related to this material.
Awais Aftab, MD. Dr. Aftab has no financial relationships with companies related to this material.
Jesse Koskey, MD. Dr. Koskey has no financial relationships with companies related to this material.
Deepti Anbarasan, MD. Associate Professor, Psychiatry and Neurology, New York University, New York, NY.
David Liebers, MD. Psychiatry resident at NYU Langone Department of Psychiatry.
The authors have no financial relationships with companies related to this material.
Kate Travis, MD. Dr. Travis has no financial relationships with companies related to this material.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.webp?t=1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
